FindTrial
Sign In

A Co-module Approach for Screening Potential Biomarker of Liver and Gallbladder Damp Heat Syndrome in Chronic Hepatitis B Patients

A Co-module Approach for Screening Potential Biomarker of Liver and Gallbladder Damp Heat Syndrome in Chronic Hepatitis B Patients

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IOR-17012066
Enrollment
Unknown
Registered
2017-07-20
Start date
2017-07-01
Completion date
Unknown
Last updated
2017-07-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Hepatitis B

Interventions

Therapy group:Yinzhihuang oral liquid and Entecavir
Contorl group:Entecavir
No typical syndrome group:Entecavir

Sponsors

Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Meet the diagnostic criteria for chronic hepatitis B; 2. TCM syndrome for Damp-heat in the Liver and Gallbladder; 3. Aged 18-65 years; 4. Signed informed consent.

Exclusion criteria

Exclusion criteria: 1. Combined with other liver diseases like other bovine liver virus infection, fatty liver, autoimmune diseases; 2. Chronic severe hepatitis, decompensated cirrhosis of liver after hepatitis B; 3. Accompanied by heart, kidney, Lung, endocrine, blood, metabolic and gastrointestinal serious primary disease 4. Psychotic patients, pregnant women and lactating women.

Design outcomes

Primary

MeasureTime frame
Efficacy index of traditional chinese medicine syndrome;—

Secondary

MeasureTime frame
Liver function;Liver function;—

Countries

China

Contacts

Public ContactYu Zhao

Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine

cathy150@139.com+86 15021115660

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026